Technology

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B.

Web Desk
By Web Desk
0 Min Read

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. .

Share This Article
Previous Article What investment gurus get wrong.
Next Article Lorde says AI glasses are ‘not sexy’.
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *